Skip to content
You can now search across every topic, entity and event.What's new
UK Startups and Innovation
7JUN

Lords question UKRI chief on funding

2 min read
10:09UTC

The House of Lords Science and Technology Committee took oral evidence from UKRI chief executive Sir Ian Chapman on Tuesday 14 July, nine days after the agency confirmed a 58% cut to its national laboratories.

TechnologyDeveloping
Key takeaway

Peers questioned UKRI's funding approach nine days after it confirmed the laboratory cuts.

The House of Lords Science and Technology Committee took oral evidence from Sir Ian Chapman, chief executive of UK Research and Innovation (UKRI), on Tuesday 14 July, on the agency's approach to funding, with a new strategy expected shortly 1. UKRI distributes public research money through nine councils and is the single largest funder of British science. We have the committee's listing for the session, not the transcript, and we are not reporting answers we have not read.

UKRI confirmed a 58% cut to Science and Technology Facilities Council (STFC) national-laboratory funding on 9 July, along with the mothballing of the Clara electron-beam facility . Removing more than half a laboratory network's budget does not slow its instruments down; it switches them off, and a mothballed accelerator is not a paused one. Restarting requires the beamline staff who by then have taken jobs at Grenoble or Hamburg, and specialist instrument engineers do not queue in the departure lounge waiting for a spending review to reverse itself.

That is the machinery a founder should watch, even one whose company has nothing to do with particle physics. National facilities are where deep-tech startups run characterisation they cannot afford in-house, and this topic has spent the month covering companies buying exactly that access from private partners instead.

Deep Analysis

In plain English

UKRI, UK Research and Innovation, is the public body that distributes government research funding through nine councils and is Britain's single largest funder of science. The House of Lords Science and Technology Committee is a group of peers who scrutinise government science policy; it is a separate body from the House of Commons committee with a similar name, and the two should not be confused. On 14 July, the Lords committee took oral evidence from UKRI's chief executive, Sir Ian Chapman, about the agency's approach to funding, with a new strategy expected soon. We have confirmation the session happened and its subject, from the committee's own published listing, but not a transcript or recording of what was actually said, so this briefing reports that the hearing took place without reporting any answers given inside it.

Deep Analysis
Root Causes

A parliamentary committee normally schedules oral evidence once a funding decision becomes contentious enough to warrant direct questioning of the agency responsible. UKRI's 58% STFC cut and the Clara mothballing, confirmed just five days before this session, is the specific decision that made a hearing on UKRI's funding approach timely rather than routine.

What could happen next?
  • Meaning

    Formal parliamentary scrutiny of UKRI's funding approach began within days of the STFC cuts becoming public, rather than being deferred to the next strategy publication.

First Reported In

Update #12 · CuspAI pools 45 partners' labs and compute

UK Parliament· 22 Jul 2026
Read original
Causes and effects
This Event
Lords question UKRI chief on funding
A new UKRI strategy is expected shortly, and the Lords session is the first formal scrutiny of the funding approach that produced the laboratory cuts.
Different Perspectives
EQT
EQT
EQT was reported on 3 July to be in advanced talks for a further CuspAI stake on behalf of the EU's Scaleup Europe Fund, but does not appear on the round CuspAI closed. Whether Europe's own sovereign vehicle secured a position, was outbid, or withdrew is unresolved.
Invest-NL
Invest-NL
Invest-NL joined CuspAI's $450m round as a new state investor alongside Britain's Sovereign AI Unit, named in the company's own 20 July announcement. Any framing of British state capital arriving must also credit Dutch capital with the same access, since Invest-NL took the opportunity too.
Kleiner Perkins and Bezos Expeditions
Kleiner Perkins and Bezos Expeditions
Kleiner Perkins and Bezos Expeditions co-led CuspAI's $450m Series B at a $2.6bn valuation, a figure Lowdown has now reported three times since June. Silicon Valley and a family office, not a UK investor, set the price of Britain's highest-profile materials-AI company.
British Business Bank
British Business Bank
British Business Bank proposed a £100m debt fund for aerospace suppliers at Farnborough on 20 July, co-designed with Airbus, Rolls-Royce and GKN Aerospace. It is the Bank's first non-equity instrument this cycle, aimed at suppliers who can service a loan but have no equity story, though the structure remains unfinalised.
Institute of Physics
Institute of Physics
The Institute has long argued STFC's national-laboratory infrastructure, not its grant programmes, is the binding constraint on UK physics output, and warns mothballing capacity like Clara removes capability that cannot be rebuilt on a four-year cycle. It represents the discovery-science community absorbing the reallocation the Bank's equity cheques do not touch.
Helsing
Helsing
The Munich-headquartered defence-AI firm chose Plymouth over Continental sites for a £350m manufacturing plant building underwater surveillance gliders, alongside its record raise. Its choice of postcode signals confidence in UK manufacturing capacity for defence hardware even as it looks abroad for the capital financing that hardware.